Lortab and Neurodermatitis - a phase IV clinical study of FDA data

Summary:

Neurodermatitis is reported as a side effect among people who take Lortab (acetaminophen; hydrocodone bitartrate), especially for people who are female, 60+ old, also take Aredia, and have Metastases to bone.

The phase IV clinical study analyzes which people have Neurodermatitis when taking Lortab. It is created by eHealthMe based on reports of 29,547 people who have side effects when taking Lortab from the FDA, and is updated regularly.

What is Lortab?

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 31,285 Lortab users. Check the latest studies of Lortab.

What is Neurodermatitis?

Neurodermatitis (a skin disorder characterized by long lasting itching and scratching) is found to be associated with 311 drugs and 276 conditions by eHealthMe. Check the latest studies of Neurodermatitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

29,547 people reported to have side effects when taking Lortab.
Among them, 40 people (0.14%) have Neurodermatitis.

Among these 40 people:

What is the gender of people who have Neurodermatitis when taking Lortab? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Neurodermatitis when taking Lortab? *

What are other drugs people take besides Lortab? *

What are other side effects people have besides Neurodermatitis? *

Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 35 people, 87.50%
Anaemia (lack of blood): 35 people, 87.50%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 35 people, 87.50%
Osteoporosis (bones weak and more likely to break): 35 people, 87.50%
Joint Pain: 34 people, 85.00%
Osteonecrosis Of Jaw (death of bone of jaw): 32 people, 80.00%
Fatigue (feeling of tiredness): 32 people, 80.00%
Fall: 32 people, 80.00%
Dyspnea (difficult or laboured breathing): 31 people, 77.50%
Chest Pain: 30 people, 75.00%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 30 people, 75.00%
Stress And Anxiety: 18 people, 45.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 7.50%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 7.50%
Arthropathy: 3 people, 7.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 2.50%
Herpes Zoster: 1 person, 2.50%
Diabetes: 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Lortab and have Neurodermatitis?

- Check whether Neurodermatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lortab:

Lortab (31,285 reports)

Neurodermatitis treatments and more:

Neurodermatitis (6,283 reports)

How severe was Neurodermatitis and when was it recovered:

Neurodermatitis in Lortab

Expand to all the drugs that have ingredients of acetaminophen; hydrocodone bitartrate:

Neurodermatitis and drugs with ingredients of acetaminophen; hydrocodone bitartrate (81 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lortab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neurodermatitis:

Neurodermatitis (311 drugs)

Browse all the conditions that are associated with Neurodermatitis:

Neurodermatitis (276 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate (the active ingredients of Lortab) and Lortab (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.